Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its new MR 7700 3.0T MR imaging system.
Amsterdam-based Philips designed the MR 7700 system to provide high accuracy to support clinical diagnostics through high-quality diffusion imaging and advanced neuroscience.
The company said in a news release that MR 7700 expands scanning capabilities with a fully integrated multi-nuclei imaging and spectroscopy solution for exploring new clinical pathways without sacrificing clinical imaging workflow or wide-bore patient comfort.
Philips’ MR 7700 has an easy-to-use interface that allows scientists and clinicians to access the scanner without compromising workflow, offering radiologists a way to image six different clinically relevant nuclei across all anatomies. The platform’s AI-driven smart connected imaging increases diagnostic confidence and adds important metabolic information to MR exams.
The company said the MR 7700 system’s XP gradient coils achieve up to 35% higher signal-to-noise ratios and up to 35% shorter scan times. Additionally, radiologists achieve 20% more fMRI volumes and 50% more diffusion tensor imaging (DTI) directions.
“Enhanced with ultra-high gradients and artificial intelligence, Philips MR 7700 is built to deliver on the high-quality clinical performance expectations of today, and to facilitate the most demanding and promising research programs that will help drive the future of MR imaging, without sacrificing workflow efficiency or wide-bore patient comfort,” Philips GM of Magnetic Resonance and Diagnostic X-ray Arjen Radder said in the release. “Combined with its AI-driven smart connected imaging capabilities, optimized workflows and integrated clinical solutions help meet the quadruple aim of healthcare by improving MR department productivity, enhancing the patient and staff experience, helping to deliver high-quality diagnostic outcomes.”
Original article:( https://www.massdevice.com/fda-clears-philips-mr-7700-imaging-system/ )